Quinoxaline peptidomimetic analogues derived from XK469 were proposed.
These derivatives tend to have similar mechanism of action with XK469.
Molecular docking studies provided visual evidences of binding modes of target compounds.
Two compounds standed out from bioevaluation and might be promising leads.